Santhera Pharmaceuticals Holding AG (Over The Counter Market:SPHDF.PK)
| 6.80 Delayed Data As of Apr 03 |  0.00 / 0.00%Today’s Change | 6.80 Today|||52-Week Range 12.00 | -- Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $85.7M |
Company Description
Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.
Contact Information
Santhera Pharmaceuticals Holding AG Hohenrainstrasse 24 Pratteln Basel-landschaft (basle Country) 4133 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Dario Eklund | Chief Executive Officer |
| Marc Schrader | Head-Technical Development & Operations |
| Andrew P. Smith | Chief Financial Officer |
| Shabir Hasham | Chief Medical Officer |
| Günther Metz | Executive VP & Head-Business Development |
